NCT00005838View on ClinicalTrials.gov

Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

756

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

February 28, 2007

Conditions
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Interventions
DRUG

shark cartilage extract AE-941

Given orally

OTHER

placebo

Given orally

DRUG

cisplatin

Given IV

DRUG

vinorelbine tartrate

Given IV

DRUG

carboplatin

Given IV

DRUG

paclitaxel

Given IV

RADIATION

radiation therapy

Undergo radiotherapy

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Radiation Therapy Oncology Group

NETWORK

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

National Cancer Institute (NCI)

NIH

NCT00005838 - Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter